CEO: Paula Soteropoulos

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Akcea Therapeutics Inc is a late stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders.


Key numbers

Market Capitalization:1813228310
Shares Outstanding: 93901000
Float: 14843682.277999999
Next Earning Date:2020-03-04
TTm EPS: -1.3825
TTm Dividend Rate:
200 days moving average:23.35
50 days moving average: 18.94
One day percent Change: 6.89



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,